See All Slides - tctmd.com

Slides

Presentation TCT 2012

Does Atrial Fibrillation Ablation Reduce Cardioembolic Stroke?

Presenter: Vivek Reddy

October 24, 2012

Presentation TCT 2012

"Impact of the Presence and Extent of Incomplete Angiographic Revascularization after Percutaneous Coronary Intervention in Acute Coronary Syndromes: The ACUITY Trial."...

Presenter: Gregg Rosner

October 24, 2012

Presentation TCT 2012

Transcatheter Mitral Valve Devices on the Horizon

Presenter: Jason Rogers

October 24, 2012

Presentation TCT 2012

Artificial Chords: When and How?

Presenter: James Gammie

October 24, 2012

Presentation TCT 2012

To Stage or Not to Stage?

Presenter: Philippe Genereux

October 24, 2012

Presentation TCT 2012

Multiple CTOs and a Calcified Critical Lesion After Failed CABG

Presenter: Wen-Lieng Lee

October 24, 2012

Presentation TCT 2012

Position Statement from a Surgeon: Transcatheter MV Replacement Is a Step Backward and Unlikely to Work!

Presenter: Michael Davidson

October 24, 2012

Presentation TCT 2012

Contrarian Position: ASCERT is Hopelessly Confounded. PCI Outcomes Are No Worse, and PCI Is More Widely Acceptable and Applicable!

Presenter: Christopher White

October 24, 2012

Presentation TCT 2012

No: In This Case Even the Most Ingenious Percutaneous Approaches Are Doomed to Fall Short!

Presenter: Patrick McCarthy

October 24, 2012

Presentation TCT 2012

Lessons from the PARTNER Trials

Presenter: Stuart Pocock

October 24, 2012

Advertisement

Slides

Does Atrial Fibrillation Ablation Reduce Cardioembolic Stroke?

"Impact of the Presence and Extent of Incomplete Angiographic Revascularization after Percutaneous Coronary Intervention in Acute Coronary Syndromes: The ACUITY Trial."...

Transcatheter Mitral Valve Devices on the Horizon

Artificial Chords: When and How?

To Stage or Not to Stage?

Multiple CTOs and a Calcified Critical Lesion After Failed CABG

Position Statement from a Surgeon: Transcatheter MV Replacement Is a Step Backward and Unlikely to Work!

Contrarian Position: ASCERT is Hopelessly Confounded. PCI Outcomes Are No Worse, and PCI Is More Widely Acceptable and Applicable!

No: In This Case Even the Most Ingenious Percutaneous Approaches Are Doomed to Fall Short!

Lessons from the PARTNER Trials

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content